Home/Filings/4/0001415889-24-020785
4//SEC Filing

Ross Thomas M. 4

Accession 0001415889-24-020785

CIK 0001287098other

Filed

Aug 4, 8:00 PM ET

Accepted

Aug 5, 6:57 PM ET

Size

14.9 KB

Accession

0001415889-24-020785

Insider Transaction Report

Form 4
Period: 2024-08-01
Ross Thomas M.
EVP, Global Sales
Transactions
  • Exercise/Conversion

    Common Stock

    2024-08-01$1.64/sh+15,476$25,39640,476 total
  • Exercise/Conversion

    Common Stock

    2024-08-02$1.64/sh+17,857$29,30342,857 total
  • Sale

    Common Stock

    2024-08-01$4.54/sh15,476$70,26125,000 total
  • Exercise/Conversion

    Employee Stock Option (right to buy)

    2024-08-0115,47617,858 total
    Exercise: $1.64Exp: 2030-01-20Common Stock (15,476 underlying)
  • Sale

    Common Stock

    2024-08-02$4.36/sh17,857$77,87425,000 total
  • Exercise/Conversion

    Employee Stock Option (right to buy)

    2024-08-0217,8571 total
    Exercise: $1.64Exp: 2030-01-20Common Stock (17,857 underlying)
Footnotes (4)
  • [F1]The sales and option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 19, 2024.
  • [F2]The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $4.445 to $4.805, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • [F3]The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $4.235 to $4.48, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • [F4]The option has fully vested.

Issuer

MAXCYTE, INC.

CIK 0001287098

Entity typeother

Related Parties

1
  • filerCIK 0001874572

Filing Metadata

Form type
4
Filed
Aug 4, 8:00 PM ET
Accepted
Aug 5, 6:57 PM ET
Size
14.9 KB